Compare Unichem Lab with Novartis - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs NOVARTIS - Comparison Results

NOVARTIS 
   Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB NOVARTIS UNICHEM LAB/
NOVARTIS
 
P/E (TTM) x -94.7 518.6 - View Chart
P/BV x 0.5 29.1 1.8% View Chart
Dividend Yield % 2.7 1.5 175.2%  

Financials

 UNICHEM LAB   NOVARTIS
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
NOVARTIS
Mar-19
UNICHEM LAB/
NOVARTIS
5-Yr Chart
Click to enlarge
High Rs292980 29.8%   
Low Rs182600 30.3%   
Sales per share (Unadj.) Rs167.7198.7 84.4%  
Earnings per share (Unadj.) Rs-3.621.0 -17.3%  
Cash flow per share (Unadj.) Rs5.922.3 26.7%  
Dividends per share (Unadj.) Rs4.0010.00 40.0%  
Dividend yield (eoy) %1.71.3 133.4%  
Book value per share (Unadj.) Rs372.3307.5 121.1%  
Shares outstanding (eoy) m70.3824.69 285.1%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.44.0 35.6%   
Avg P/E ratio x-65.337.7 -173.2%  
P/CF ratio (eoy) x39.935.5 112.4%  
Price / Book Value ratio x0.62.6 24.8%  
Dividend payout %-110.247.7 -231.0%   
Avg Mkt Cap Rs m16,68019,508 85.5%   
No. of employees `0002.60.6 447.8%   
Total wages/salary Rs m2,3931,171 204.4%   
Avg. sales/employee Rs Th4,535.28,445.4 53.7%   
Avg. wages/employee Rs Th919.82,015.7 45.6%   
Avg. net profit/employee Rs Th-98.2891.0 -11.0%   
INCOME DATA
Net Sales Rs m11,8014,907 240.5%  
Other income Rs m984783 125.7%   
Total revenues Rs m12,7855,689 224.7%   
Gross profit Rs m-835123 -679.9%  
Depreciation Rs m67432 2,118.6%   
Interest Rs m7516 473.0%   
Profit before tax Rs m-600858 -69.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-343340 -101.0%   
Profit after tax Rs m-256518 -49.4%  
Gross profit margin %-7.12.5 -282.7%  
Effective tax rate %57.339.6 144.5%   
Net profit margin %-2.210.6 -20.5%  
BALANCE SHEET DATA
Current assets Rs m20,3848,055 253.1%   
Current liabilities Rs m5,0291,850 271.8%   
Net working cap to sales %130.1126.4 102.9%  
Current ratio x4.14.4 93.1%  
Inventory Days Days10545 232.7%  
Debtors Days Days13534 397.7%  
Net fixed assets Rs m9,023150 6,023.6%   
Share capital Rs m141123 114.1%   
"Free" reserves Rs m26,0587,469 348.9%   
Net worth Rs m26,1997,592 345.1%   
Long term debt Rs m00-   
Total assets Rs m31,4969,824 320.6%  
Interest coverage x-7.054.9 -12.7%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.5 75.0%   
Return on assets %-0.65.4 -10.5%  
Return on equity %-1.06.8 -14.3%  
Return on capital %-2.011.5 -17.4%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18858 14,215.3%   
Fx outflow Rs m5961,326 44.9%   
Net fx Rs m7,592-1,269 -598.4%   
CASH FLOW
From Operations Rs m-3,278-1,943 168.7%  
From Investments Rs m-2,8602,742 -104.3%  
From Financial Activity Rs m-24-298 8.1%  
Net Cashflow Rs m-4,690501 -935.6%  

Share Holding

Indian Promoters % 50.1 0.0 -  
Foreign collaborators % 0.0 75.0 -  
Indian inst/Mut Fund % 15.1 2.0 755.0%  
FIIs % 3.0 1.6 187.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 21.5 147.4%  
Shareholders   20,176 41,647 48.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SANOFI INDIA  TORRENT PHARMA  FRESENIUS KABI ONCO.  WYETH LTD  ABBOTT INDIA  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Higher; Bharti Airtel & SBI Top Gainers(12:30 pm)

Share markets in India are presently trading on a strong note tracking positive global cues. The BSE Sensex rose over 350 points intraday, while the NSE Nifty climbed above 11,950.

Related Views on News

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Crash Alert! Is There a Big Bubble in Nestle, HUL and Asian Paints?(Profit Hunter)

Nov 7, 2019

Is this the beginning of the end of multibagger gains in quality stocks like Nestle, HUL, and Asian Paints?

These 10 Days Are Crucial for Getting Rich in the Smallcap Rebound(Profit Hunter)

Nov 5, 2019

How to avoid the most common investing mistake and make the most of the smallcap rebound.

Why Moody's Rating Downgrade is a Strong Sign to Buy Stocks(The 5 Minute Wrapup)

Nov 8, 2019

Investors who took cues from Moody's rating downgrade in 1992 and 2002 created some of the biggest wealth of their lifetime.

The Top Stocks for 2020 Pass This Most Critical Metric(The 5 Minute Wrapup)

Nov 5, 2019

Charlie Munger's favorite fictional character, Mr Glotz, picks stocks using this metric.

What to Buy at Sensex 40,000(The 5 Minute Wrapup)

Nov 4, 2019

Should you invest in high-quality, safe stocks or make some contrarian bets in the smallcap space?

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Nov 15, 2019 03:25 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS